Jasper Therapeutics, Inc.
- JSPR
- NASDAQ
- Biotechnology
- Monoclonal Antibody Therapies
- Stem Cell Research
$0.48
Today −9.81%Quote Oct 16, 2026, 08:00 PM UTC
−24.32%over the last month
Max drawdown −24.3%From 1-month high −24.3%3 months −41.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$16.0M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$2.50
+420.9% from here
Floor
$0.46
4.1% below price
Where the price sits
13 analysts
Analyst range, low to high
$2.00$3.00
- Price $0.48
- Resistance $0.48
- Consensus $2.50
The price is right under resistance. Analysts' average target sits about 421% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about JSPRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
22
Founded
2018